New research evaluates RA patients' cardiovascular risks Rheumatologists also mull advances, complications of drug therapy
Rheumatology (ACR) focused on cardiovascular and other non-rheumatological consequences of the disease. ... The opening ceremony welcomes attendees to the 71st annual meeting of the American College of Rheumatology.
Narrowing the focus on fibromyalgia. If attendees at the Association of Rheumatology Health Professionals' fibromyalgia debate were expecting strident disagreement, they were likely disappointed.
In my last ACR session (the convention continues through tomorrow, but our blog coverage finishes today), a psychiatrist spoke about explain...
O’Dell, FACP, a professor of medicine in the rheumatology section at the University of Nebraska. ... When we go to non-rheumatology practices, the rates of use are much lower,” Dr.
In the field of rheumatology, we are often faced with complex decisions, but luckily, the majority of them are not extremely time-sensitive, allowing us time to research and discuss with ... Paul, Minn. He was a chief resident in internal medicine with
MD, chief of the Division of Rheumatology at Montefiore Medical Center and Albert Einstein College of Medicine in New York. ... Nat Clin Pract Cardiovasc Med. 2005; 2:423-30. [PMID: 16119705]. Hochberg MC.Updating the American College of Rheumatology
From ACR today: The good news is that a new study found that TNF-antagonists do not increase the risk of cancer for patients with rheumato...
The point of the rheumatologic press conference I attended this afternoon was probably supposed to be the results of the research presented,...
Fellowship: Yale School of Medicine (rheumatology), 1992-1994. Present positions: Private practice, Northeast Medical Group with the Yale-New Haven Health System; associate clinical professor, Yale School of Medicine, New Haven, ... ACP Fellowship: 1998.
There's something pleasingly efficient about research that finds new applications for existing therapies. A few such studies were presented ...